MarkNtel Advisors recently published a detailed industry analysis of the Asia-Pacific Proteomics Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Insights and Analysis of the Asia-Pacific Proteomics Market (2023-2028)

The Asia-Pacific Proteomics Market is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e., 2023-28.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/apac-proteomics-market.html

What is driving the Asia-Pacific Proteomics market?

Rising Need for New Drug Development Augmented the Demand for Proteomics Services – The rising prevalence of chronic diseases such as cancer, arthritis, chronic obstructive pulmonary disease, etc., across APAC, has been propelling pharmaceutical companies & biotech companies like Takeda, Pfizer, etc., to advance their research & development of new drugs & therapies.

As a result, the demand for proteomics services has increased since these testing services were used at various stages of drug development, such as preclinical testing, clinical trials, and others. Also, in recent years, to expedite the proteomics process various key technological developments have been observed, such as the inclusion of orbitrap mass spectrometry & protein microarrays. For instance:

• In 2022, Thermofisher Scientific Inc. launched Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers, the first time equipped with charge detection capabilities, allowing direct mass determination of hundreds to thousands of individual ions in a single spectrum.

Moreover, advancements in proteomics have expanded the scope to develop novel therapeutic therapies in recent years. As a result, biotechnology companies like Merck, GE Healthcare, etc., are increasingly investing in the research and development of drugs, as well as adopting new technologies in proteomics. These investments and technological advancements are expected to accelerate the market growth of proteomic services in the forecast years.

What segments define the Asia-Pacific Proteomics market from 2023 to 2028? How do these segments contribute to market dynamics and growth?

By Technology

(Spectroscopy, Chromatography, Electrophoresis, Protein Microarray, Microarray Instrument, Crystallography, Surface Plasma Resonance, Fractionation, Others (X-Ray Crystallography, Enzyme-linked Immunosorbent Assay, etc.)),

By Reagent

(Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Others (Glycobiology Agents, Phos-tag, etc.)),

By Offering,

(Core Proteomics Service, Software & Services),

By Indication,

(Oncology, Infectious Diseases, Diabetes, Neurological Disorder, Autoimmune Diseases, Cardiovascular Diseases, Others (Gastrointestinal, Lung disease, etc.)),

By End-User

(Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories),

By Country,

(China, India, Japan, South Korea, Australia, Singapore, Rest of the Asia-Pacific)

Explore the Complete Asia-Pacific Proteomics Market Analysis Report – https://www.marknteladvisors.com/research-library/apac-proteomics-market.html

Who are the leading key players shaping the Asia-Pacific Proteomics Market landscape?

Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare, Thermofisher Scientific Inc., Merck KgaA, Promega Corporation, Bruker Corporation, Waters Corporation, MRM Proteomics Inc., Luminex Inc., Perkin Elmer Inc., and others

Questions Addressed in this Study

1.What factors are driving the Asia-Pacific Proteomics Market growth?

2.How is the Asia-Pacific Proteomics Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Asia-Pacific Proteomics Market?

4.What is the current size of the Asia-Pacific Proteomics Market, and how is it projected to change in the future?

6.What is the future outlook for the Asia-Pacific Proteomics Market in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/apac-proteomics-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 |  +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India